Overview

Intra-Arterial Microdosing: Proof-of-Concept in Humans

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this protocol is to demonstrate that intra-arterial administration of a drug can generate information in a manner that faithfully mimics effects of systemic administration but with little or no systemic effects.
Phase:
Early Phase 1
Details
Lead Sponsor:
Duke University
Treatments:
Insulin
Insulin, Globin Zinc